SuperworthRevolution Medicines market cap RVMD
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $40.1B
- Highest close in our data
- $45B
- Sep 2026
Revolution Medicines is worth $40.1B at the close on Oct 23, 2026, at $186.99 a share.
That is up 294% over the last year and up 1751% over five years.
Its highest close in our data was $45B in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $40.1B | $15.3B | $45B | +157% |
| 2025 | $15.6B | $5.8B | $15.6B | +110% |
| 2024 | $7.4B | $3B | $10.2B | +137% |
| 2023 | $3.1B | $1.9B | $3.8B | +49% |
| 2022 | $2.1B | $1.2B | $2.3B | +14% |
| 2021 | $1.9B | $1.8B | $3.6B | −29% |
| 2020 | $2.6B | $1.4B | $3B | n/a |
Against its peers
Companies in Biotechnology nearest Revolution Medicines' size, closest first, today.
| Company | Market cap |
|---|---|
| RVMDRevolution Medicines | $40.1B |
| ONCBeOne Medicines | $42.9B |
| ALNYAlnylam Pharmaceuticals | $30B |
| UTHRUnited Therapeutics | $25.2B |
| INCYIncyte | $23.5B |
| REGNRegeneron Pharmaceuticals | $82.9B |
| EXELExelixis | $16B |
| NBIXNeurocrine Biosciences | $14.5B |
| HALOHalozyme Therapeutics | $14.3B |
| VRTXVertex Pharmaceuticals | $132.8B |
| TECHBIO-TECHNE | $11.4B |
| Peer median | $24.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Revolution Medicines
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.